Merck Delivers Resilient Growth Across All Divisions in Q1 2025, Advances Strategic Expansion with SpringWorks Acquisition Merck, the global science and technology powerhouse, began 2025 on strong footing, demonstrating solid financial and operational performance in the face of ongoing macroeconomic…
Regeneron Triumphs in Landmark Antitrust Case Against Amgen Over PCSK9 Inhibitor Market Practices In a major legal victory that could have lasting implications for the biotechnology and pharmaceutical industries, Regeneron Pharmaceuticals, Inc. (NASDAQ: REGN) announced it has prevailed in an…
WHO Establishes Expert Surgical Sub-Group to Develop Global Guidelines for Caesarean Section Practices Caesarean section, often referred to as C-section, has become the most common major abdominal surgery performed across the globe. What was once a surgical intervention reserved primarily…
Sarepta’s ELEVIDYS Gene Therapy Gains Landmark Approval in Japan for Duchenne Muscular Dystrophy Sarepta Therapeutics, a biotechnology leader in precision genetic medicine for rare diseases, has announced a significant regulatory milestone: the Japanese Ministry of Health, Labour and Welfare (MHLW)…
Legend Biotech Reports Strong First Quarter 2025 Performance and Strategic Milestones as CARVYKTI® Continues to Lead in Multiple Myeloma Legend Biotech Corporation, a global frontrunner in the field of cell therapy, has reported its financial results for the first quarter…
WuXi Biologics Ireland: Pioneering Sustainable Biomanufacturing Through Purpose-Driven Innovation In an era where sustainability has become a defining metric of corporate integrity and resilience, WuXi Biologics Ireland stands out as a biopharmaceutical leader integrating environmental, social, and governance (ESG) values…
CMS Prepares Third Cycle of Drug Price Negotiations Under IRA as Trump Administration Revives Push to Lower U.S. Prescription Costs In a move that signals the growing momentum of federal efforts to control prescription drug costs, the U.S. Centers for…
Bayer Reaffirms 2025 Outlook Following Robust First-Quarter Performance, Showcases Strength in Pharmaceuticals and Strategic Advancements in Crop Science Bayer AG has started 2025 with a strong operational footing, underscoring confidence in its full-year guidance amid an increasingly complex economic and…
AstraZeneca Unveils Expansive Respiratory Portfolio and Pioneering Clinical Data at ATS 2025 to Advance Care Across Asthma, COPD, and Inflammatory Lung Diseases AstraZeneca is poised to make a significant impact at the 2025 American Thoracic Society (ATS) International Conference in…
TVC Partners with Norbrook to Bring Felanorm™ to Independent Veterinary Practices The Veterinary Cooperative (TVC), the premier group purchasing organization dedicated to supporting independent veterinary practices across the United States, is proud to announce a groundbreaking partnership with Norbrook Animal…
Orca Bio Unveils New Leadership Team Changes Orca Bio, a late-stage biotechnology company dedicated to transforming the treatment landscape for patients through its cutting-edge high-precision cell therapies, has announced an important leadership transition. The company’s co-founder and Chief Scientific Officer…
Hansoh Pharma’s Ameile Gains Approval for New Indication in Early-Stage EGFR-Mutant NSCLC Hansoh Pharmaceutical Group Co., Ltd (03692.HK), hereafter referred to as Hansoh Pharma, announced that its innovative product Ameile (almonertinib mesylate tablets) has received approval in China for a…